Biosafety involves the safe use of biological materials in research, such as infectious or disease containing organisms, recombinant DNA technologies, bloodborne pathogens, human tissues, vectors of disease, and zoonotic agents, among others. The Biosafety Officer at EHS works with the Institutional Biosafety Committee (IBC), a group of faculty research experts and community representatives to help insure safe research protocols, labs, and equipment. Guidelines issued by the Centers of Disease Control and Prevention and the National Institutes of Health are adhered to. Ohio University maintains a Biosafety Program and Manual for researchers.

• Information for Researcher Using Biological Materials
• Including what biological materials are covered and when IBC approval is required.
• Institutional Biosafety Committee
• Including: information, bylaws and schedule
• Related Ohio University program documents and forms
• Infectious Waste

 

Regulations, Guidelines & Web Resources

• Related program documents and forms
• NIH published "Investigator Responsibilities"

 

OSHA Regulations:

• Bloodborne Pathogens (29 CFR 1910.1030)
• Chemical Hygiene (Lab) 29 CFR 1910.1450
• Personal Protective Equipment 29 CFR 1910 Subpart I
• Formaldehyde 29 CFR 1910.1048

CDC & NIH Guidelines & Regulations:

• CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
• NIH Guidelines for Research Involving Recombinant DNA Molecules
• Agent Transfer  (Select Agent Rule) Law

Web Resources:

• CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
• American Biological Safety Association
• CDC Information on Hepatitis
• USEPA TSCA Biotechnology Program
• NIH Office of Recombinant DNA Activties
• DOT Transporting Infectious Substances Safely
• “Biosafety in the Laboratory”
• Infectious Substances MSDSs from the Public Health Agency of Canada

Additional online information